Results of a multicentre study show that a sequential high-dose chemotherapy variant of the standard treatment is safe and effective in relapsed Hodgkin’s patients.
Related Articles
Featured
In the US, costs of breast cancer treatments vary wildly
Cover Story
Frederic Amant: building the evidence base for saving mother and child
Senza categoria